I understand your position vrs37 that all the evidence isn’t in...

I understand your position vrs37 that all the evidence isn’t in yet. I’ve invested based on current valuations and what’s possible, and thus far I feel like the strategy they’ve laid out, what GK often refers to in interviews as being 1 year in to a 3 year plan, is on track.

I’m just wondering for you what valuation you’d give the company if the current phase 2 trials were a success, or in other words what’s the threshold for you when you’d be interested in buying NOX. I assume you must be interested in the company to here and active on the boards.

Rather than these entrenched Vrs vs. holders debate I’m keen to know what your investment strategy is around NOX